Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for PhytoHealth Corp. (4108:TWSE), powered by AI.
PhytoHealth Corp. is currently trading at $12.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for PhytoHealth Corp. on Alpha Lenz.
View PhytoHealth Corp.'s valuation metrics on Alpha Lenz.
“PhytoHealth Corp.'s ROE is -3.1%. Explore profitability and growth together.”
Ask for details →PhytoHealth Corp. is a biotechnology company specializing in the development and commercialization of botanical-based pharmaceuticals. The primary function of PhytoHealth Corp. is to research and produce innovative therapeutic products derived from plant sources, aimed at improving health outcomes across various medical fields. The company's focus on botanical-based solutions positions it at the intersection of traditional medicine and modern pharmaceutical advancements. As part of the broader biotechnology sector, PhytoHealth Corp. plays a crucial role in providing alternative medical treatments and has a significant impact on sectors such as oncology, neurology, and immunology. In the financial market, PhytoHealth Corp. is noteworthy for its dedication to drug discovery that harnesses natural ingredients, catering to a growing demand for more holistic and sustainable healthcare solutions. Headquartered in Taiwan, the company contributes to the global pharmaceutical landscape by emphasizing the potential of nature to supplement modern medicine's therapeutic arsenal.
“PhytoHealth Corp.'s ROE is -3.1%. Explore profitability and growth together.”
Ask for details →PhytoHealth Corp. (ticker: 4108) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 12 with a P/E ratio of -x and P/B of -x.
ROE is -3.08% and operating margin is -129.73%. Annual revenue is $135M.